Correlation analysis between biochemical and biophysical markers of endothelium damage in children with diabetes type 1;Ocena korelacji miȩdzy biochemicznymi i biofizycznymi markerami uszkodzenia śródbłonka u dzieci z cukrzyca̧ typu 1

Endokrynologia, Diabetologia i Choroby Przemiany Materii Wieku Rozwojowego

Volumn 11, Issue 4, 2005, Pages 221-227

  Głowińska Olszewska, Barbara ^a   Urban, Mirosława ^a   Tołwinska, Joanna ^a   Peczyńska, Jadwiga ^a   Florys, Bozena ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Adhesion molecules; Children; Diabetes; Endothelium; FMD; IMT

Indexed keywords

BIOCHEMICAL MARKER; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1; BIOLOGICAL MARKER;

ADOLESCENT; ANALYTIC METHOD; ARTERY DILATATION; ARTERY INTIMA; ARTICLE; ATHEROSCLEROSIS; BRACHIAL ARTERY; CAROTID ARTERY; CHILD; CORRELATION ANALYSIS; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; BLOOD; CASE CONTROL STUDY; COMMON CAROTID ARTERY; DIABETES MELLITUS; ECHOGRAPHY; ENZYME IMMUNOASSAY; METABOLISM; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; VASCULAR ENDOTHELIUM; VASODILATATION;

ADOLESCENT; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BRACHIAL ARTERY; CAROTID ARTERY, COMMON; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; CHILD; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; E-SELECTIN; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTERCELLULAR ADHESION MOLECULE-1; MALE; P-SELECTIN; PREDICTIVE VALUE OF TESTS; VASCULAR CELL ADHESION MOLECULE-1; VASODILATION;

EID: 27144529606     PISSN: 1234625X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Anderson T. J.: Assessment and treatment of endothelial dysfunction in humans. J. Am. Coll. Cardiol., 1999, 34, 631.
2. Blake G.J., Ridker P.M.: Novel clinical markers of vascular wall inflammation. Circ. Res., 2001, 89, 763.
3. Blankenberg S., Barbaux S., Tiret L.: Adhesion molecules and atherosclerosis. Atherosclerosis, 2003, 170, 191.
4. Blann A.D., Lip G.Y.: Endothelial integrity, soluble adhesion molecules and platelet markers in type 1 diabetes mellitus. Diabet. Med., 1998, 15, 634.
5. Blann A.D., Lip G.Y.: The endothelium in atherothrombotic disease: assessment of function, mechanisms and clinical implications. Blood Coagul. Fibrinolysis, 1998, 9, 297.
6. Boulbou M.S., Koukoulis G.N., Makri E.D. i wsp.: Circulating adhesion molecules levels in type 2 diabetes mellitus and hypertension. Int. J. Cardiol., 2005, 98, 39.
7. Brevetti G., Martone V.D., de Cristofaro T. i wsp.: High levels of adhesion molecules are associated with impaired endothelium-dependent vasodilation in patients with peripheral arterial disease. Thromb. Haemost., 2001, 85, 63.
8. Celermajer D.S.: Noninvasive detection of atherosclerosis. N. Engl. J. Med., 1998, 339, 2014.
9. Celermajer D.S., Sorensen K.E., Gooch V.M. i wsp.: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet, 1992, 340, 1111.
10. Ceriello A., Falleti E., Bortolotti N i wsp.: Increased circulating intercellular adhesion molecule-1 levels in type II diabetic patients: the possible role of metabolic control and oxidative stress. Metabolism, 1996, 45, 498.
11. Clausen P., Jacobsen P, Rossing K. i wsp.: Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with type 1 diabetes mellitus with microalbuminuria and overt nephropathy. Diabet. Med., 2000, 17, 644.
12. Cominacini L., Fratta Pasini A., Garbin U. i wsp.: Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control. Diabetologia, 1995, 38, 1122.
13. Dogra G.K., Watts G.F., Chan D.C, Stanton K.: Statin therapy improves brachial artery vasodilator function in patients with type 1 diabetes and microalbuminuria. Diabet. Med., 2005, 22, 239.
14. Dogruel N., Kirel B., Akgun Y., Us T.: Serum soluble endothelial-cell specific adhesion molecules in children with insulin-dependent diabetes mellitus. J. Pediatr. Endocrinol. Metab. 2001, 14, 287.
15. Elhadd T.A., Abdu T.A., Oxtoby J. i wsp.: Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency. J. Clin. Endocrinol. Metab., 2001, 86, 4223.
16. Elhadd T.A., Kennedy G., Hill A. i wsp.: Abnormal markers of endothelial cell activation and oxidative stress in children, adolescents and young adults with type 1 diabetes with no clinical vascular disease. Diabetes Metab. Res. Rev., 1999, 15, 405.
17. Fuchsjager-Mayrl G., Pleiner J., Wiesinger G.F. i wsp.: Exercise training improves vascular endothelial function in patients with type 1 diabetes. Diabetes Care, 2002, 25, 1795.
18. Hillis G.S., Flapan A.D.: Cell adhesion molecules in cardiovascular disease: a clinical perspective. Heart, 1998, 79, 429.
19. Holmlund A., Hulthe J., Millgard J. i wsp.: Soluble intercellular adhesion molecule-1 is related to endothelial vasodilatory function in healthy individuals. Atherosclerosis, 2002, 165, 271.
20. Hunt B.J., Jurd K.M.: Endothelial cell activation. A central pathophysiological process. BMJ, 1998, 316, 1328.
21. Hwang S.J., Ballantyne C.M., Sharrett A.R. i wsp.: Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation, 1997, 96, 4219.
22. Jarvisalo M.J., Putto-Laurila A., Jartti L. i wsp.: Carotidartery intima-media thickness in children with type 1 diabetes. Diabetes, 2002, 51, 493.
23. Jarvisalo M.J., Raitakari M., Toikka J.O. i wsp.: Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation, 2004, 109, 1750.
24. John S., Jacobi J., Delles C. i wsp.: Plasma soluble adhesion molecules and endothelium-dependent vasodilation in early human atherosclerosis. Clin. Sci. (Lond.), 2000, 98, 521.
25. Kondo K., Kitagawa K., Nagai Y. i wsp.: Associations of soluble intercellular adhesion molecule-1 with carotid atherosclerosis progression. Atherosclerosis, 2005, 179, 155.
26. Krantz J.S., Mack W.J., Hodis H.N. i wsp.: Early onset of subclinical atherosclerosis in young persons with type 1 diabetes. J. Pediatr., 2004, 145, 452.
27. Krolewski A.S., Kosinski E.J., Warram J.H. i wsp.: Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am. J. Cardiol., 1987, 59, 750.
28. Libby P., Ridker P.M., Maseri A.: Inflammation and atherosclerosis. Circulation, 2002, 105, 1135.
29. Lim S.C., Caballero A.E., Smakowski P. i wsp.: Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without micro-albuminuria. Diabetes Care, 1999, 22, 1865.
30. Nathan D.M., Lachin J., Cleary P. i wsp.: Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N. Engl. J. Med., 2003, 348, 2294.
31. Pena A.S., Wiltshire E., Gent R. i wsp.: Folic acid improves endothelial function in children and adolescents with type 1 diabetes. J. Pediatr., 2004, 144, 500.
32. Pignoli P., Tremoli E., Poli A. i wsp.: Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation, 1986, 74, 1399.
33. Rembold K.E., Ayers C.R., Wills M.B., Rembold C.M.: Usefulness of carotid intimal medial thickness and flow-mediated dilation in a preventive cardiovascular practice. Am. J. Cardiol., 2003, 91, 1475.
34. Rohde L.E., Lee R.T., Rivero J. i wsp.: Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 1998, 18, 1765.
35. Ross R.: Atherosclerosis - an inflammatory disease. N. Engl. J. Med., 1999, 340, 115.
36. Schram M.T., Chaturvedi N., Schalkwijk C. i wsp.: Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care, 2003, 26, 2165.
37. Singh T.P., Groehn H., Kazmers A.: Vascular function and carotid intimal-medial thickness in children with insulin-dependent diabetes mellitus. J. Am. Coll. Cardiol. 2003, 41, 661.
38. Slyper A.M.: Clinical review 168: What vascular ultrasound testing has revealed about pediatric atherogenesis, and a potential clinical role for ultrasound in pediatric risk assessment. J. Clin. Endocrinol. Metab., 2004, 89, 3089.
39. Widlansky M.E., Gokce N., Keaney J.F. Jr., Vita J.A.: The clinical implications of endothelial dysfunction. J. Am. Coll. Cardiol., 2003, 42, 1149.
40. Witte D.R., Broekmans W.M., Kardinaal A.F. i wsp.: Soluble intercellular adhesion molecule 1 and flow-mediated dilatation are related to the estimated risk of coronary heart disease independently from each other. Atherosclerosis, 2003, 170, 147.